Heparin Immobilization Enhances Hemocompatibility, Re-Endothelization, and Angiogenesis of Decellularized Liver Scaffolds
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252212132 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Chandra Jit Yadav und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, Chungbuk National University, Cheongju 28644, Republic of Korea. Hauptthemen laut MEDLINE: Heparin, Tissue Scaffolds, Liver, Neovascularization, Physiologic. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korean fund for Regenerative Medicine (KFRM) (the Ministry of Science and ICT, the Ministry of Health & Welfare), Korean Fund for Regenerative Medicine (KFRM) grant (the Ministry of Science and ICT, the Ministry of Health and Welfare).
Abstract (Originalsprache)
Bioengineered livers are currently an acceptable alternative to orthotopic liver transplants to overcome the scarcity of donors. However, the challenge of using a bioengineered liver is the lack of an intact endothelial layer in the vascular network leading to thrombosis. Heparin-modified surfaces have been demonstrated to decrease thrombogenicity in earlier research. However, in our study, we aimed to apply heparin immobilization to enhance the hemocompatibility, endothelial cell (EC) adhesion, and angiogenesis of rat decellularized liver scaffolds (DLS). Heparin was immobilized on the DLS by the end-point attachment technique. The scaffold’s hemocompatibility was assessed using ex vivo blood perfusion and platelet adhesion studies. The heparinized scaffold (HEP-DLS) showed a significantly reduced thrombogenicity and platelet aggregation. HEP-DLS was recellularized with EA.hy926 cells via the portal vein and maintained in the bioreactor for 7 days, showing increased EC adhesion and coverage within the blood vessels. The Resazurin reduction assay confirmed the presence of actively proliferating cells in the HEP-DLS. The scaffolds were implanted subcutaneously into the dorsum of mice for 21 days to evaluate cell migration and angiogenesis. The results showed significant increases in the number of blood vessels in the HEP-DLS group. Our results demonstrated that heparin immobilization reduces thrombosis, promotes re-endothelialization, and enhances angiogenesis in DLS. The research provides insight into the potential use of heparin in the formation of a functioning vasculature.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Veterinary Medicine, Chungbuk National University, Cheongju 28644, Republic of Korea.
ORCID-Profile: Usha Yadav
Förderung
- Korean fund for Regenerative Medicine (KFRM) (the Ministry of Science and ICT, the Ministry of Health & Welfare)
- Korean Fund for Regenerative Medicine (KFRM) grant (the Ministry of Science and ICT, the Ministry of Health and Welfare)
Zitieren
APA
Yadav, C. J., Yadav, U., Afrin, S., Lee, J. Y., Kamel, J., & Park, K. M. (2024). Heparin Immobilization Enhances Hemocompatibility, Re-Endothelization, and Angiogenesis of Decellularized Liver Scaffolds. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252212132
Vancouver
Yadav CJ, Yadav U, Afrin S, Lee JY, Kamel J, Park KM. Heparin Immobilization Enhances Hemocompatibility, Re-Endothelization, and Angiogenesis of Decellularized Liver Scaffolds. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252212132
BibTeX
@article{Yadav2024,
author = {Yadav, Chandra Jit and Yadav, Usha and Afrin, Sadia and Lee, Jun-Yeong and Kamel, Jihad and Park, Kyung-Mee},
title = {Heparin Immobilization Enhances Hemocompatibility, Re-Endothelization, and Angiogenesis of Decellularized Liver Scaffolds},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252212132}
}
EUVIMED